ARCHIVES

Also in this 8-page issue: Dept. of Justice, Congress to investigate Merck and FDA actions on Vioxx; FDA asks IOM to study its monitoring system for approved drugs.

This article is from The Cancer Letter archive.

Vol. 30 No. 43 | November 12, 2004

Download PDF Visit The Full Archive

Related Articles

Marvin Schneiderman To Retire March 1

February 8, 1980

The Pink Machine Sputters, Goes in Reverse: Komen Funding Decision Sparks Outrage

February 3, 2012

Retrospective Data Clean-Up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”.

February 15, 2002

New System Devised To Help Identify Emerging Comprehensive Centers

October 10, 1975

Stop Cancer Foundation’s Future In Question, May Not Deliver All Of Funds Promised to NCI

January 18, 1991

Professional Societies: ASCO opposes FDA On Stem Cell Transplant Regs

May 16, 1997